Introduction
T he number of outcome instruments available has increased substantially since the last outcome symposium was published in The Journal of Bone and Joint Surgery 1 .
The proliferating number of scales that are available complicates the choice faced by investigators during selection of the most appropriate instrument [2] [3] [4] . Quality criteria have recently been proposed to assess the measurement properties of health-status instruments 2, 5 . Outcome instruments can be used for several purposes, including the evaluation of patients in clinical practice 6 or clinical research 1 . Because the focus of this supplement is on nonrandomized studies, we will refer to outcome instruments that are useful in a clinical research setting rather than on those that are useful in the assessment of individual patients during daily clinical work 4 . However, an extremely important use of these tools is to improve care. This can be accomplished by routinely instituting the use of validated instruments in daily clinical practice and by modifying treatment protocols on the basis of the results.
Clinical outcomes, such as those obtained through the imaging of fractures and through physical examination to assess range of motion 3, 7, 8 (traditionally described as objective or hard measures), are valuable in orthopaedic research. Unfortunately, these measures can be subject to interrater disagreement and they often do not provide definitive answers about whether an intervention is useful from a patient's perspective 9 . Furthermore, objective measures may also correlate poorly with a patient's own feelings of wellness 9 . In addition to objective measures, the orthopaedic literature often includes patientreported, or subjective or soft outcome measures, such as the measurement of pain or satisfaction following a procedure 3, 10 . Well-designed patient-reported instruments have undergone rigorous testing and may be better validated and have greater reproducibility than the so-called objective outcomes 3 . Thus, outcome objectivity is not determined by whether a clinician measures a parameter directly, but rather it is dependent on the reliability or reproducibility of a finding 11 . It cannot be stated that, by definition, objective measures are better than subjective measures or the other way around.
The most important feature of outcome instruments is their ability to test whether treatment is effective in improving symptoms or function from a patient's point of view 9 . Many funding agencies and research ethic boards insist that a qualityof-life instrument (instruments that capture a wider perspective of the state of well-being) be included in the design of proposed clinical studies 9 . In an effort to standardize outcome measurement and reporting in arthroplasty research, The Journal of Bone and Joint Surgery strongly encourages inclusion of the Western Ontario and McMaster University Osteoarthritis Index (WOMAC) in studies that report the results of hip and knee arthroplasty.
In this article, we will discuss types of outcome instruments, suggest a conceptual model that will help eliminate confusing terminology such as ''hard'' and ''soft,'' discuss how to locate the appropriate outcome instruments, describe a method to evaluate outcome instruments on the basis of quality criteria, and discuss the potential pitfalls in utilizing outcome instruments for research purposes. Moreover, we will only refer to validated outcome instruments.
The Conceptual Model of Patient Outcomes as Proposed by Wilson and Cleary

W
ilson and Cleary proposed a classification scheme for different measures of health outcome (Fig. 1) 12 . They conceptualized five levels of outcomes: 1) biological and phys-iological variables (level one), 2) symptom status (level two), 3) functional status (level three), 4) general health perceptions (level four), and 5) overall quality of life (level five) 12 . They stated that the concepts of this model (i.e., the concepts encountered when following the levels from left to right across Fig.  1 ) become increasingly integrated and increasingly difficult to define and measure 12 . Furthermore, they explained that, as one draws closer to level five of the model (the right side of Fig. 1) , there are an increasing number of inputs, such as characteristics of the individual (symptom amplification, personality and motivation, and values and preferences), characteristics of the environment (psychological supports, social and economic supports, and social and psychological supports), and nonmedical factors that cannot be controlled by clinicians or by the healthcare system as it is traditionally defined 12 . Biological and physiological factors (level one) are commonly conceptualized, measured, and applied in daily clinical practice 12 . Examples include the diagnosis of osteoarthritis, fracture, or osteosarcoma; increased activity on a bone scan; or a meniscal tear seen on a magnetic resonance image.
The focus then moves from specific cells or organs to the organism as a whole when symptoms are assessed (level two) 12 .
At this level, both biological and physiological factors play a role. Patients can have physiological abnormalities, such as osteoporosis, without having symptoms. On the other hand, symptoms may not correlate to radiographic findings, such as the lack of radiographic abnormalities in the presence of back pain. Thus, we need to be careful about the way that we interpret measures of biological function, as factors other than biology may influence how a symptom presents. However, symptoms are often the primary reason why patients seek medical attention, and therefore we need to further explore the inconsistent relationship between biological factors and symptoms 12 .
Functional status (level three) is also listed as an outcome in the model proposed by Wilson and Cleary. Symptoms, such as pain, have an impact on the functional status of a patient; however, the personality and motivations of the patient are also influential. Additionally, the social environment plays an important role. Functional status is an important outcome to be measured in observational studies. Relationships between symptoms and function clearly exist, but variations in functioning cannot always be fully explained. Therefore, all five levels of outcome need to be measured in an observational study.
General health perceptions (level four) are an assimilation of the previously described levels of outcome. These general health perceptions have been shown to be allied with biological and physiological factors; however, many other factors, including patient expectations, affect a patient's perception of health, resulting in large variations within each stage of clinical severity.
Finally, overall quality of life (level five) is the broadest outcome. This includes a wide range of nonmedical factors as well as experiences and feelings that humans have. Interestingly, functional status was not as strongly associated with happiness as one might expect 12 . It is hypothesized that patients may be able to adapt to their impairment 13 . In contrast to the levels of evidence, a hierarchy in quality does not exist in the outcome levels. A higher level merely illustrates the complexity of the measurement, and the different levels of outcome should coexist in observational studies. Types of Outcome Instruments F ollowing the model as described above, we can identify several outcome instruments. Radiographs or other types of imaging and laboratory tests are the outcome measures that focus on biological and physiological factors in orthopaedic research. Symptoms in the orthopaedic patient are frequently pain, stiffness, and loss of strength, and these symptoms are usually captured during physical examination. To structure this examination, clinician-based outcome instruments (such as the Knee Society score) were developed 14 . Furthermore, grip dynamometers, the Jebsen- Taylor Test of Hand Function   15 , and the ''Get-Up and Go'' test 16 are some additional examples of tools that are helpful during the physical examination.
Mixed Clinician-Based and Functional Outcome Instruments
Frequently utilized in past and present orthopaedic research are mixed clinician-based and functional outcome instruments (these instruments are comprised of questions answered by patients and physical examination performed by the outcome assessor). Often, these instruments are not validated and their outcomes are frequently dependent on the technique of the administrator. Range of motion is often a component of mixed scoring systems such as the Harris hip score and the Constant shoulder assessment 17, 18 . If physical examination or clinical tests are a part of a scoring system, there is a high risk of interobserver variability 4 . Furthermore, the weight applied to subscales or items that are often spread over different levels of the model by Wilson and Cleary may be arbitrary. In addition, if scores such as pain and hip flexion are combined into one single numerical measure, this single number may yield noninformative conclusions 4, 19 . For example, a patient may have an increased range of motion but still have pain or, alternatively, the pain may have subsided but the stiffness still exists. In addition, the patient may have a small amount of improvement in both pain and stiffness scores. Summarizing these findings in a single number is not helpful to investigators or clinicians and will not discriminate between improving and worsening patients.
Apart from mixed clinician-based instruments, other combinations are possible. The biological and physiological variables, symptom status, and functional status levels in the model by Wilson and Cleary are commonly combined. The symptom status, general health perceptions, and overall quality-of-life levels are also possible combinations in mixed outcome instruments. Use of the labels of the level may clarify matters better than use of the term mixed clinician-based instruments, as both biological and physiological variables and functional status instruments may be clinician based.
We recommend not using mixed clinical and functional outcome instruments because validated outcome instruments that will yield reproducible results are now available.
System-Specific Outcome Instruments and Disease-Specific Instruments
System-specific instruments are developed to evaluate conditions related to one body region or, more specifically, one joint.
A system-specific instrument covers several diseases related to the given body region. For example, several patient-reported outcome instruments are devoted to the knee 20 . Condition or disease-specific instruments evaluate the well-being of patients with a specific disease. For example, a patient population with osteoarthritis of the hip can be evaluated with a system-specific instrument for the hip, but they can also be evaluated with a disease-specific instrument that focuses on osteoarthritis. Another example comes from carpal tunnel syndrome research. The Boston Carpal Tunnel Questionnaire is valid for the population, has good reliability, and is responsive 21 . We encourage the use of a disease-specific instrument, when available, to improve sensitivity to change. Symptom or diseasespecific instruments typically have a higher sensitivity than that obtainable with generic quality-of-life instruments. Measurement properties are discussed in more detail below.
General Health-Related Quality-of-Life Instruments
Health-related quality of life is a multifactorial concept 12 . It comprises physical, mental, and social factors 9 . These factors, when combined, describe a person's health and deal with a broad range of daily activities, such as work, hobbies, and social interactions (Wilson and Cleary level four). Thus, health-related quality of life is how a person's health affects his or her ability to carry out normal social and physical activities. General health-related quality-of-life instruments are designed to measure this wide range of health status. In orthopaedics, the Sickness Impact Profile, the Nottingham Health Profile, and the Short Form-36 (SF-36) 22 are most frequently used 4 . More recently, the Short Form-12 (SF-12) has been developed 23 . The SF-12 comes with the advantage of being able to produce the two summary scales (initially developed from the SF-36) with considerable accuracy but with far less respondent burden 24 . Accordingly, the SF-12 may be an outcome instrument of choice for a situation in which a short, generic measure providing summary information on physical and mental health status is mandatory 24 . Moreover, the Musculoskeletal Function Assessment (MFA) instrument and, more recently, the Short Musculoskeletal Function Assessment (SMFA) instrument have been developed 25, 26 . These two instruments have demonstrated good validity and are commonly used in musculoskeletal research 25, 26 .
Overall Quality-of-Life Instruments Happiness or satisfaction during daily activities or tasks is often as important to individuals as their ability to participate in these daily activities 9, 12 . To capture the patients' overall quality of life (Wilson and Cleary level five) 12 , quality-of-life outcomes have been developed. An example includes the Quality of Well-Being (QWB) questionnaire 27 .
Finding and Selecting an Outcome Instrument S electing an outcome instrument starts with the proposed research question 9 . After carefully framing the objective of the study, the next step is to locate instruments most suitable to evaluate the intervention under investigation and the patient population to be included in the study. One of the most effective methods of selecting an appropriate instrument is to consult with experienced musculoskeletal clinical researchers. Ideally, the selected outcome instruments will evaluate all five levels of outcome as proposed by Wilson and 
The next step is to conduct a literature search. Consulting a librarian is often beneficial and can improve the efficiency and the results of a literature search. Using the ''Clinical Queries'' feature in PubMed to find the most up-to-date systematic reviews that evaluated outcome instruments is often helpful. As of this writing, specific search strategies 29 , such as those developed for randomized controlled trials, are currently lacking and are undergoing further evaluation. Table I lists the key contemporary systematic reviews that are relevant to musculoskeletal outcome instruments. Once an outcome instrument has been selected from a systematic review, one can apply quality criteria as described below to select the most appropriate instrument. In our example, two reviews could guide us 30, 31 . Furthermore, several researchers have published compendiums of instruments to aid in the selection of outcome instruments 32 . Additionally, the use of validated instruments in a daily clinical setting has been shown to improve care. Current guidelines recommend that practitioners who would like to improve patient care should assess patient outcomes with use of a validated condition-specific instrument and focus on the functional aspects of the disease or injury secondarily 25 .
Quality Criteria for Outcome Instruments
A ny new outcome instrument needs to be developed with use of strict methodological safeguards. Suggested quality criteria are mostly opinion based because there is no empirical evidence in this field to support explicit quality criteria 2, 9 . Terwee et al. proposed a checklist of quality criteria to evaluate the methodological soundness of patient-reported outcome instruments 2 . These criteria include: content validity, internal consistency, criterion validity, construct validity, reproducibility (agreement and reliability), responsiveness, floor and ceiling effects, and interpretability 2 . Below, we describe these quality criteria for patient outcome instruments in more detail 2 .
Content Validity
Content validity is the extent to which the domain of interest is comprehensively sampled by the items in the instrument 2 . The developers of an outcome instrument should consider that the measurement aim of the instrument is important and that the content is tailored to the population of interest. For example, in a study evaluating patients with instability of the knee, a question about return to sports may be relevant. However, another instrument focusing on the knee may have relevant questions with respect to osteoarthritis (i.e., pain or stiffness), but these questions may be less relevant to a patient who has painless giving-way and who is unable to return to sports 33 . Therefore, the investigators have to choose an instrument that is relevant to the aim of the outcome to be measured, given the patient population of interest.
Internal Consistency
Internal consistency is the extent to which items in a scale or subscale are intercorrelated, thus measuring the same construct 2 . Different items or subscales in the instrument can ask the same questions in a slightly different manner to truly capture the respondent's opinion or level of function. The Cronbach alpha is considered an adequate measure of internal consistency, and it should be calculated for each scale or subscale separately 2 . A low Cronbach alpha indicates a lack of correlation between the items in a scale, which makes summarizing the items unjustified. A very high Cronbach alpha reflects high correlations among the items in the scale, which indicate the redundancy of one or more items 2 .
Criterion Validity
Criterion validity is the extent to which scores on a particular instrument relate to a so-called gold standard 2 . If a gold standard is available, the outcome instrument can be compared with this standard. However, as a gold standard is frequently unavailable, construct validity has to be assessed.
Construct Validity
Construct validity refers to the extent to which scores on a particular instrument relate to other measures in a manner that is consistent with theoretically derived hypotheses concerning the concepts that are being measured 2 . In their paper on quality criteria, Terwee et al. explained: Without specific a priori hypotheses, for example, about expected correlations between changes in instruments measuring the same concept, or expected differences in changes between ''known'' groups, ''the risk of bias is high because retrospectively it is tempting to think up alternative explanations for low correlations instead of concluding that the questionnaire may not be valid.'' 2 Reproducibility Reproducibility refers to the degree to which repeated measurements (test-retest) in steady populations provide similar answers. Reproducibility is built on agreement and reliability. Agreement is the extent to which the scores on repeated measures are close to each other (absolute measurement error). Reliability is the extent to which patients can be distinguished from each other, despite measurement errors (relative measurement error).
Responsiveness
Responsiveness is the ability of an instrument to detect clinically important changes over time 2 . Terwee et al. offered further clarification of this concept when they said: ''We consider responsiveness to be a measure of longitudinal validity. In analogy to construct validity, longitudinal validity should be assessed by testing predefined hypotheses, e.g., about expected correlations between changes in measures, or expected differences in changes between 'known' groups. This shows the ability of a questionnaire to measure changes if they really have happened. Furthermore, the instrument should be able to distinguish clinically important change from measurement error.'' scores the highest possible score (that is, best health status) preoperatively, the outcome instrument cannot measure improvement after the treatment. This ceiling effect may be observed when outcome instruments that were designed to evaluate patients with severe disease are used to evaluate patients who are more fit. For example, an instrument designed to evaluate elderly patients with osteoarthritis is less suitable for evaluating improvement after treatment in a group of athletes. This example stresses the importance of choosing an instrument according to the population for which it was originally designed.
Interpretability
Interpretability is the degree to which one can assign qualitative meaning to quantitative scores 2 . A difference of five points between two treatment groups on a scale ranging from 0 to 100 points may be significant, but this does not mean that such a small difference is also clinically relevant. An instrument with a high degree of reproducibility may be able to detect small changes 34 ; however, investigators should decide a priori on the clinical relevance of the spectrum of that scale. On a 100-point scale, are patients with a 5-point higher score really experiencing an important change, or is a change in health status as reflected in a difference of 20 points the minimally important change 35, 36 ? This raises an important issue, especially since calculations regarding sample size are often performed on the best estimates of ''important treatment effects.'' Not only is the choice of a primary end point important, but the relevance of change on a scale should also be known 35, 36 .
Pitfalls Involved with the Use of Outcome Instruments in Orthopaedic Research
Other Methodological Considerations I f multiple outcome instruments are used in an observational study, then positive results can be an effect of chance alone 37 . The occurrence of an erroneous false-positive conclusion is designated as a type-I or alpha error. Therefore, investigators should carefully choose the most appropriate outcome instrument a priori. We advise researchers to consider choosing an instrument for each outcome level unless the intervention is specifically focused on one or two levels. For example, if the intervention is aimed to help patients cope with their symptoms, it would not be necessary to make use of the Wilson and Cleary classification system to measure biological and physiological variables. The advice to cover several levels will result in multiple end points. Five well-defined outcome measures will strengthen a study, thus covering all aspects of orthopaedic outcome measurement. It is important, however, that the investigators define their primary outcome of interest, as multiple end points increase the risk of having false-positive results 37 . If multiple outcomes are used, a statistical correction, (that is, the Bonferroni method) is recommended 37, 38 . For instance, if an investigator plans to conduct five tests of significance on five different outcome measures and report significance at the p < 0.05 level, the effective probability value is not 0.05 but rather can be approximated by a rule of thumb (5 outcomes · 0.05 = 0.25). Using this rule of thumb, there is a 25% chance of having a false-positive result among the five outcome measures. To limit such incorrect conclusions (alpha errors), the alpha level of significance can be adjusted from 0.05 to 0.01 (0.05 O 5 outcomes = 0.01) 37 . Data dredging (this process refers to multiple testing until one test shows positive results without the use of an a priori hypothesis) can be a problem in retrospective case series, in which protocols can be adjusted to the investigator's convenience after analyzing the data, thus resulting in flawed conclusions.
Another hazard exists when only the parts of the instrument that show a significant result after statistical testing are reported, not the complete instrument. Instruments are designed to be used in their original form, since the instrument was validated as such. Modification of validated outcome instruments without revalidation may result in flawed conclusions 39, 40 . After modification of an outcome instrument, the instrument should undergo the same rigorous validation process as the original instrument did 39 . Simply adding or removing questions for one's own convenience violates the validity of an outcome instrument and is strongly discouraged. Orthopaedic research will have more impact if a core set of unmodified outcome instruments are used in all observational studies.
Application of an outcome instrument needs to be accomplished by blinded or independent study personnel to help reduce bias. Although it is the patient who provides the outcome that is assessed, there is always a risk that an interviewer may have guided the responses of the patient 39 . Unblinded outcome assessment may yield a threefold increase in treatment effect 39 . In addition, if patients believe that the information that they give on a questionnaire about symptoms or function will be reported to their treating surgeon, they often will not provide accurate information because they may appreciate the surgeon's efforts to help them and because they may not want to disappoint. This is why it is so critical to use blinding techniques or enlist the services of someone who is independent of the treating team to administer the instrument.
Cultural and Linguistic Considerations for a Specific Population
A patient from the United States may respond differently to certain questions than a patient from the United Kingdom would, even though both are native English speakers 4 . Depending on the geographic locations involved, words can have subtly different meanings. Therefore, it is very important to consider the population on which the outcome instrument was originally tested 41 . Language barriers are another difficulty in clinimetrics (a methodological discipline that focuses on the quality of clinical measurements, e.g., diagnostic characteristics and disease outcomes). Simply translating a previously validated instrument is insufficient 42 . The translated instrument needs to be
revalidated before it can be utilized in clinical or research settings. The Disabilities of the Arm, Shoulder and Hand (DASH) outcome measure is an example of a validated instrument that has been translated into several languages [43] [44] [45] [46] . Other translated and validated instruments focus on hip and knee osteoarthritis (e.g., the Hip Disability and Osteoarthritis Outcome Score [HOOS] 47, 48 , the Knee Injury and Osteoarthritis Outcome Score [KOOS] 49 , and the Oxford 12-Item Knee Questionnaire 50 ). These issues are becoming increasingly important for multicenter cohort studies.
Mental conditions, such as posttraumatic conditions, may complicate the ability of patients to fill out instruments. Injury may also physically impair the patient's hand function and thus the patient's ability to respond to a mailed instrument requiring a written response. Jackowski and Guyatt summarized methods to administer outcome instruments (Table II) 9 .
The Future of Outcome Measurement I n the future, the development of a computer-based outcome assessment that incorporates the item response theory may bring much progress 51 , but, until then, the standardization of outcome instrument use in orthopaedic research will be a giant leap forward. Ideally, a core set of validated patient-reported outcome instruments should be used in orthopaedic research. We should take a lesson from rheumatology research, in which standardization of outcome measurement has brought much success 52 . Additionally, pain researchers have put substantial efforts into producing consensus outcome measures 53 . Reaching consensus is not an easy process, however, and the results from consensus meetings need to be subject to ongoing debate 54 . Still, investigators could use these core instruments and then choose additional outcome instruments, if needed, to suit the unique nature of their study. The use of universal, previously validated outcome instruments will facilitate a comparison of results of different studies and will also facilitate subsequent metaanalysis 55 . Before embarking on the development of yet another outcome instrument, investigators should perform a systematic review to evaluate the current state of the art 56 . In terms of improving patient care, there is much more to be gained from utilizing the currently available instruments in clinical outcomes research than from developing a new instrument.
Summary
V alidated outcome instruments are a useful tool in orthopaedic research. Unfortunately, not all instruments have been developed with use of strict quality criteria. The conceptual model of patient outcomes that was proposed by Wilson and Cleary can help in choosing an instrument to measure all five levels of outcome 15 . The proposed criteria of Terwee et al. may help in future validation of outcome instruments 2 . As the number of validated outcome instruments continues to increase, a method of standardization, based on evidence and international consensus, could be helpful in future orthopaedic research and may improve the quality of patient care. n
